Pain Management Company Virpax Sees Promise in Potential COVID-19 Antiviral OTC

Nov 17, 2021

admin2022-10-21T08:55:59-04:00November 17th, 2021|Media|

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com